Autoimmune Disease Diagnostics Market Size

Industry Autoimmune Disease Diagnostics Market Size

Autoimmune Disease Diagnostics Market size was valued at around USD 1,104 million in 2021 and is estimated to register over 6.6% CAGR between 2022 and 2030. The rising incidence of autoimmune diseases and the adoption of automation for equipment are some of the vital pointers that are propelling the global market growth.

To get key market trends

  Download Free Sample

Autoimmune disorders develop when the immune system attacks its own cells in the body as a result of abnormalities. The failure to detect immune cells, tissues & organs and produce autoantibodies targeting these cells causes the immune system to malfunction. Therefore, several initiatives are implemented by organizations to create awareness about autoimmune diseases and socioeconomic impact, thereby boosting the usage rates of autoimmune disease diagnostics, globally. Additionally improved laboratory automation and technological advancements in diagnostics are driving the autoimmune disease diagnostics market expansion.

Autoimmune diseases are an ailment of the immune system that attacks one or more normally functioning cells of the body owing to the asymmetry or irregularities. The malfunctioning of the immune system is mainly due to the inability of the cell to recognise tissues, immunological cells, and other organs that produce autoantibodies against these cells

However, need for high capital investment in setting-up diagnosis centers and slow turnaround time for test results as well as need for multiple diagnostic tests can adversely affect the market growth. The diagnostics centers for autoimmune disease diagnostics are associated with stringent government regulations, and diagnostic complications that may negatively impact the business expansion. Several types of blood test such as C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), enzyme-linked immunosorbent assay (ELISA), rheumatoid factor (RF), etc. are done to detect the type and severity of autoimmune disease.

These tests have a long turnaround time due to several procedures to determine the positivity with accuracy. For instance, the rheumatoid factor (RF) test to determine rheumatoid arthritis take more than 2 days for the result. Similarly, the C-reactive protein (CRP) test to measure the level of CRP in blood takes over 3 days for the test results. As a result, the slow turnaround time associated with the use of standard disease diagnostic techniques, as well as the presence of fewer modern testing technologies, are some of the limitations further hindering the industry growth.

The COVID-19 pandemic emerged as an unprecedented global pandemic, affecting the healthcare sector by disrupting the global supply chain. During the initial phase of the outbreak, in the first half of 2020, the pandemic hampered the growth of the autoimmune disease diagnostics market. National emergencies and lockdowns were imposed in numerous countries to prevent the spread of the COVID-19 virus. The lockdown and travel restrictions had a negative influence on health systems.

The coronavirus pandemic had an impact on the autoimmune disease diagnostics business by restricting product uptake and associated procedures. It had an impact on consumer and manufacturers by significantly reducing and delaying the number of non-emergency surgical procedures conducted and patients assessed for eligibility of autoimmune disease diagnostics.

According to the reports of the National Center of Biotechnology Information (NCBI), in 2021, the patients suffering from the rheumatoid arthritis (RA) had a high risk of developing COVID-19. This led in more stringent operational procedures, that elevated the product demand. The combined efforts of certain regulatory authorities and market players contributed to reducing the impact of the pandemic. Furthermore, autoimmune disease diagnostics reached pre-pandemic diagnostic volume in 2021. Thus, the COVID-19 pandemic delayed industry growth marginally; however, restoring surgical volume would help market expansion in the near future.